metricas
covid
Buscar en
Annals of Hepatology
Toda la web
Inicio Annals of Hepatology P-47 DEGREES OF LIVER STIFFNESS AND STEATOSIS AS PREDICTORS OF PREECLAMPSIA COMP...
Información de la revista
Vol. 29. Núm. S3.
Abstracts of the 2023 Annual Meeting of the ALEH
(diciembre 2024)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 29. Núm. S3.
Abstracts of the 2023 Annual Meeting of the ALEH
(diciembre 2024)
Acceso a texto completo
P-47 DEGREES OF LIVER STIFFNESS AND STEATOSIS AS PREDICTORS OF PREECLAMPSIA COMPLICATIONS
Visitas
11
Jose Luis Perez Hernandez1, Andres Tonatihu Flores Flores2, Daniel Santana Vargas1, Orestes de Jesus Cobos Quevedo1, Jesus Carlos Briones Garduño1, Fatima Higuera de la Tijera1
1 hospital General de México "Dr Eduardo Liceaga, Ciudad De México, México
2 Hospital Central Sur de Alta Especialidad Pemex, Ciudad De México, México
Este artículo ha recibido
Información del artículo
Resumen
Texto completo
Descargar PDF
Estadísticas
Figuras (1)
Suplemento especial
Este artículo forma parte de:
Vol. 29. Núm S3

Abstracts of the 2023 Annual Meeting of the ALEH

Más datos
Conflict of interest

No

Introduction and Objectives

Liver damage in preeclampsia is caused by antiangiogenic factors such as soluble tyrosine kinase, placental growth factor, and soluble endoglin. These induce endothelial injury and fibrin deposits in the hepatic microcirculation, thus modifying the physical characteristics of the liver parenchyma and therefore its stiffness. Objectives: To evaluate the correlation between the degree of liver stiffness and the severity of patients with preeclampsia.

Patients / Materials and Methods

This study was observational, analytical, cross-sectional, and prospective. It included pregnant women from the 20th week of gestation, dividing them into three groups: those with a normal pregnancy, those with pre-eclampsia, and those with severe features of pre-eclampsia. Transient elastography was conducted on all participants. Pregnant women with chronic systemic arterial hypertension or pre-existing liver diseases were excluded. Descriptive statistics for measures of central tendency were utilized, and a univariate analysis was performed, considering kilopascals as the dependent variable, the three groups as fixed factors, and BMI as a covariate.

Results and Discussion

34 patients were included, 9 in the control group, 12 in the preeclampsia group and 13 in the preeclampsia with severity features group. The mean gestational age was 32 ± 5.8 weeks. The mean age was 27.26 ± 7.73 years. The mean BMI was 28.88 ± 4.83. The mean kPa in the control group was 4.35 ± 0.98, in the preeclampsia without severity features group 5.05 ± 0.87, and in the preeclampsia with severity features group 6.67 ± 1.84. The mean control group CAP was 202.82 ± 21.26 db/m2, in the preeclampsia without severity features group was 227.81 ± 47.81 db/m2, and in the preeclampsia with severity features group was 215.28 ± 37.41 db/m2. Univariate contrasts were significant for preeclampsia with severity criteria features versus preeclampsia F (2 of 23) = 7.679, p = 0.011. Preeclampsia with severity features versus control F (2 of 22) = 11.134, p = 0.003

Conclusions

Liver stiffness significantly increases in patients with preeclampsia and preeclampsia with severity features measured by transient elastography. This increase is due to intrahepatic fibrin deposition, but not by fibrosis (collagen) itself. Transient elastography could be useful as a predictor of severity in patients with preeclampsia.

Texto completo

Ethical statement: Study approved by the research ethics committee of the General Hospital of Mexico registration key DI/23/310-E/03/37.

figure 1

Descargar PDF
Opciones de artículo
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos